Lipidavit Sl Zur Anwendung Bei Erwachsenen Und Heranwachsenden Ab 12 Jahre

Phospholipids from soybeans, the active ingredient in Lipidavit Sl Zur Anwendung Bei Erwachsenen Und Heranwachsenden Ab 12 Jahre, is a phospholipid presented as a nutritional supplement for oral use. It supports liver and digestive health in adults and adolescents from 12 years of age.

GNH USA supplies Lipidavit Sl Zur Anwendung Bei Erwachsenen Und Heranwachsenden Ab 12 Jahre as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lipidavit Sl Zur Anwendung contains phospholipids from soybeans, which are used to support hepatic and digestive functions.

- Liver support: helps maintain normal liver function and may protect hepatocytes. - Digestive health: contributes to normal fat digestion and absorption. - Nutritional supplementation: provides essential phospholipids for cell‑membrane integrity and overall metabolic balance.

Adverse reactions to phospholipid supplements are generally mild and infrequent.

Common Side Effects: - Nausea: mild stomach upset after ingestion. - Diarrhea: loose stools in sensitive individuals. - Abdominal discomfort: transient cramping or bloating. - Flatulence: increased gas production. - Headache: occasional mild headache. - Allergic skin rash: rare cutaneous reaction.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction in persons with soy allergy. - Hepatic enzyme elevation: uncommon increase in liver function tests. - Severe gastrointestinal bleeding: extremely rare, usually in conjunction with anticoagulant therapy. - Angioedema: swelling of face, lips, or throat. - Persistent vomiting: prolonged emesis requiring medical attention. - Hypotension: rare drop in blood pressure associated with systemic allergic response.

When considering Lipidavit Sl Zur Anwendung, several safety measures should be observed.

- Allergy assessment: avoid use in individuals with known soy or legume allergy. - Pregnancy and lactation: consult a healthcare professional before use during pregnancy or breastfeeding. - Concomitant liver disease: use under medical supervision if existing hepatic conditions are present. - Anticoagulant therapy: monitor coagulation parameters if taken with blood‑thinning agents. - Pediatric use: intended only for persons aged 12 years and older. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Phospholipid supplements may influence the absorption or activity of certain medicines.

Major Interactions (Avoid): - Warfarin: may increase anticoagulant effect and bleeding risk. - Orlistat: can reduce the absorption of phospholipids, diminishing supplement efficacy.

Moderate Interactions (Monitor Closely): - Fat‑soluble vitamins (A, D, E, K): may alter their absorption; monitor vitamin levels. - Statins: potential additive effect on liver metabolism; observe liver function tests. - Immunosuppressants (e.g., cyclosporine): possible impact on drug plasma concentrations. - Thyroid hormone replacement: monitor thyroid function as phospholipids may affect hormone absorption.